Heart. Published Online First: 28 April 2009. doi:10.1136/hrt.2008.164608
Editorials |
Point of care testing in acute coronary syndromes- when and how?
1 University of Leeds, United Kingdom
* To whom correspondence should be addressed. E-mail: c.p.gale{at}leeds.ac.uk.
Accepted 7 April 2009
Abstract
Despite advances in their treatment, acute coronary syndromes (ACS) continue to carry significant mortality and morbidity[1]. Identifying higher risk patients, and hence selecting those who would most benefit from more aggressive therapies, forms an integral approach to ACS management and outcome[1 2]. Such stratification of patients on admission (near-point testing) is based on patient-specific variables which have been shown in randomised controlled trials (RCT) and observational databases to be associated with mortality. The logistic regression of these variables on clinical outcomes to generate scores of risk has sought to help physicians identify patients for whom tailored therapy would offer a reduction in mortality risk.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
